课题基金 / 基金详情

The Cryptococcus neoformans Redoxome: The role of Rac GTPases in ROS Signal Transduction and Titanisation

The Cryptococcus neoformans Redoxome: The role of Rac GTPases in ROS Signal Transduction and Titanisation
新型隐球菌氧化还原体:Rac GTPases 在 ROS 信号转导和钛化中的作用
批准号:
BB/M014525/1
负责人:
Elizabeth Ballou
金额:
$37.36万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

Elizabeth Ballou的其他基金

相似基金

相关文献

中文摘要
翻译
当细胞生长和分裂时,它们必须同时协调许多复杂的事件。母细胞必须将其所有的生长导向萌芽的子细胞,然后必须复制并正确地分享其DNA,将一个拷贝给子细胞,并为自己保留一个拷贝。如果没有这些事件的紧密协调,子细胞和母细胞就会死亡。因此,细胞已经进化出详细的机制来紧密协调生长,DNA复制和DNA分布。然而,一些细胞已经找到了解决这个问题的另一种方法:即使它们的DNA数量错误,它们也能够存活。这种存活被称为基因组可塑性,因为在这些细胞中,DNA的拷贝数,也被称为基因组,是可塑的。癌症是显示基因组可塑性的细胞的一个关键例子。在这些细胞中,拥有许多基因组拷贝为细胞提供了更多的工具来生长和逃避药物治疗。具有基因组可塑性的细胞的另一个例子是真菌病原体新型隐球菌。隐球菌每年影响全球近100万人,并在感染后三个月内杀死近三分之二的感染者。隐球菌生长在肺部。在健康的人中,免疫系统能够对抗这种增长,但在患有潜在疾病的人中,包括艾滋病毒和自身免疫疾病,免疫系统被削弱。在长期使用免疫抑制剂(如类固醇)以对抗器官移植排斥反应的人群中,每20人中就有1人患上隐球菌病。在这些个体中,隐球菌会逃离肺部进入大脑,如果不及时治疗,会导致脑膜炎和死亡。正常的隐球菌细胞只有一个DNA拷贝,但隐球菌也会形成一种独特的结构,称为泰坦细胞,包含许多DNA拷贝。特别引人注目的是,泰坦细胞仍然能够保持这种DNA的组织性,并且在萌芽期间只给它们的女儿一个副本。顾名思义,泰坦隐球菌细胞比普通细胞大10倍。这类似于一个樱桃气球到足球大小。这些巨大的细胞太大了,我们的免疫细胞无法摧毁,它们也会产生新的小细胞,这些小细胞可以逃逸到血液中并引起疾病。没有人知道Cryptococcus Titan细胞是如何形成的。一个线索是隐球菌使用称为ROS的分子作为细胞中的信使。在其他生物体中,ROS发送信号以帮助协调生长。我已经证明了ROS缺陷的隐球菌突变体在生长上也有缺陷。此外,控制ROS的相同因素也控制基因组可塑性。总之,这表明ROS、生长和基因组可塑性可能相关。例如,ROS可能在出芽过程中充当信使,告诉母细胞何时分配DNA。当这个信号被改变时,泰坦细胞可能会形成。本奖学金的研究将调查隐球菌如何完成这项任务。由于隐球菌使用泰坦细胞来抵抗药物治疗,因此了解泰坦细胞的工作原理以及如何防止其形成将有助于我们开发更好的药物。
英文摘要
When cells grow and divide, they must simultaneously coordinate a number of complex events. The mother cell must direct all of its growth to the budding daughter cell and then must duplicate and correctly share out its DNA, giving one copy to the daughter and keeping one copy for itself. Without tight coordination of these events, daughter and mother cells die. As a consequence, cells have evolved detailed mechanisms to tightly coordinate growth, DNA duplication and DNA distribution. Some cells have found another way around this problem, however: They are able to survive even when they have the wrong amount of DNA. This survival is called genome plasticity because in these cells, the number of copies of DNA, also known as the genome, is malleable. Cancer is one key example of cells displaying genome plasticity. In these cells, having many copies of the genome gives the cell more tools to grow and to evade drug treatment. Another example of cells with genome plasticity is the fungal pathogen Cryptococcus neoformans. Cryptococcus affects nearly 1 million people each year worldwide, and kills nearly two thirds of those infected within three months of infection. Cryptococcus grows in the lungs. In healthy people, the immune system is able to combat this growth, but in people with underlying diseases, including HIV and auto-immune diseases, the immune system is weakened. Among people on long-term immune suppressors, such as steroids to combat organ transplant rejection, 1 in 20 develop cryptococcosis. In these individuals, Cryptococcus escapes the lung and goes to the brain, where it causes meningitis and death if left untreated.Normal Cryptococcus cells have a single copy of their DNA, but Cryptococcus also makes a unique structure called a Titan cell that contains many DNA copies. What is particularly striking is that Titan cells are still able to keep this DNA organised and give only one copy to their daughters during budding. As the name suggests, Cryptococcus Titan cells are much larger than ordinary cells -10 times bigger. This is similar to a cherry ballooning to the size of a football. These huge cells are too big for our immune cells to destroy, and they also produce new small cells that can escape into the blood and cause disease. No one knows how Cryptococcus Titan cells are formed. One clue is that Cryptococcus uses molecules called ROS as messengers in the cell. In other organisms, ROS send signals to help coordinate growth. I have shown that Cryptococcus mutants that are defective in ROS are also defective in growth. Additionally, the same factors that control ROS also control genome plasticity. Together, this suggests that ROS, growth and genome plasticity may be related. For example, ROS may act as messengers during budding that tell the mother cell when it is time to distribute DNA. Titan cells may form when this signal is altered. The research in this Fellowship will investigate how Cryptococcus accomplishes this task. Because Cryptococcus uses Titan cells to resist drug treatment, understanding how Titan cells work and how to prevent their formation will help us develop better drugs.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Lactate signalling regulates fungal ß-glucan masking and immune evasion.
乳酸信号调节真菌α-葡聚糖掩蔽和免疫逃避。
DOI: --
发表时间: 2016
期刊:
影响因子: --
作者: [[]]
通讯作者: []
DOI: 10.1016/j.cub.2022.01.028
发表时间: 2022-03-14
期刊: Current biology : CB
影响因子: --
作者: [Itabangi H, Sephton-Clark PCS, Tamayo DP, Zhou X, Starling GP, Mahamoud Z, Insua I, Probert M, Correia J, Moynihan PJ, Gebremariam T, Gu Y, Ibrahim AS, Brown GD, King JS, Ballou ER, Voelz K]
通讯作者: Voelz K
DOI: 10.1016/j.mib.2016.05.013
发表时间: 2016-08
期刊: Current opinion in microbiology
影响因子: 5.4
作者: [Ballou ER, Wilson D]
通讯作者: Wilson D
DOI: 10.1101/190587
发表时间: 2017-09
期刊: PLoS Pathogens
影响因子: 6.7
作者: [I. Dambuza;Thomas A. Drake;A. Chapuis;L. Taylor-Smith;Nathalie M. Legrave;T. Rasmussen;M. Fisher;T. Bicanic;T. Harrison;M. Jaspars;R. May;Gordon D. Brown;R. Yuecel;D. MacCallum;Elizabeth R. Ballou]
通讯作者: I. Dambuza;Thomas A. Drake;A. Chapuis;L. Taylor-Smith;Nathalie M. Legrave;T. Rasmussen;M. Fisher;T. Bicanic;T. Harrison;M. Jaspars;R. May;Gordon D. Brown;R. Yuecel;D. MacCallum;Elizabeth R. Ballou
共 6 条
    Investigating microbial predation as a driver of endosymbiosis and phagocyte evasion
    • 批准号:
      BB/W002760/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $101.66万
    • 财政年份:
      2022
    • 负责人:
      Elizabeth Ballou
    • 依托单位:
    The Cryptococcus neoformans Redoxome: The role of Rac GTPases in ROS Signal Transduction and Titanisation
    • 批准号:
      BB/M014525/2
    • 项目类别:
      Fellowship
    • 资助金额:
      $15.06万
    • 财政年份:
      2017
    • 负责人:
      Elizabeth Ballou
    • 依托单位:
    国内基金
    海外基金
    新生隐球菌减数分裂特异性基因ISC10的生理功能研究